FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US
STOCKHOLM, Jan. 14, 2025, 21:51 GMT-05
BIOARCTIC-FDA
Read full article →
Category
Healthcare
This category brings together content related to healthcare, medicine, clinical research, healthcare services, medical devices, therapies and the development of solutions for the sector. Sector classification by EMSF Lisboa.
Exosome Therapies Market Poised for Explosive Growth During the Study Period (2025-2034) | DelveInsight
LAS VEGAS, Jan. 13, 2025, 17:31 GMT-05
DelveInsight-Business
Read full article →
Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma
SHANGHAI and NORTH CHICAGO, Ill., Jan. 13, 2025, 09:05 GMT-05
Simcere-Abbvie
Read full article →
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
DUBLIN, Calif. and JENA, Germany, Jan. 13, 2025, 09:00 GMT-05
CarlZeissMeditecAG
Read full article →
Q'Apel Medical Announces CE Mark Approval for Armadillo SelectFlex™ Neurovascular Access System
FREMONT, Calif., Jan. 13, 2025, 08:51 GMT-05
Q'Apel-Medical
Read full article →
Endo Launches New Peyronie's Disease Campaign: I Got Somebody
MALVERN, Pa., Jan. 13, 2025, 07:30 GMT-05
Endo-Peyronie-Disease
Read full article →
Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A
HELSINKI, Jan. 13, 2025, 06:30 GMT-05
Rappta-Therapeutics
Read full article →
Diamyd Medical updates U.S. market potential for Diamyd®
STOCKHOLM, Jan. 13, 2025, 02:55 GMT-05
DIAMYD-MEDICAL-U.S.
Read full article →
W. L. GORE & ASSOCIATES, INC. RECEIVES CE MARK FOR LOWER PROFILE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS, NOW 6 FR SHEATH COMPATIBLE
PUTZBRUNN, Germany, Jan. 13, 2025, 01:07 GMT-05
WL-Gore-CE-Mark
Read full article →
Chronic Disease Management: Innovations in Therapeutics, Devices, and Global Markets
BOSTON, Jan. 10, 2025, 12:48 GMT-05
BCC-Research-LLC
Read full article →
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
FLORENCE, Italy and CAMBRIDGE, Mass., Jan. 10, 2025, 10:45 GMT-05
MENARINI-Insilico
Read full article →
Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPD
COPENHAGEN, Denmark, Jan. 10, 2025, 09:33 GMT-05
Novo-Holdings-Announc
Read full article →
David Schilansky Appointed Chief Financial Officer of Ariceum Therapeutics
BERLIN, Jan. 10, 2025, 03:30 GMT-05
Ariceum-Therapeutics
Read full article →
NCCN Joins International Meeting to Improve Cancer Care in the Middle East and North Africa Region
RIYADH, Saudi Arabia, Jan. 10, 2025, 04:03 GMT-05
NCCN-MiddleEast
Read full article →
FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025
HERZLIYA, Israel and CALGARY, Alberta, Jan. 9, 2025, 16:01 GMT-05
Innocan-Fee-Waiver
Read full article →
Global Biotechnology Market Outlook 2025: Driving Growth at 13.0% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Jan. 9, 2025, 10:30 GMT-05
MARKETSANDMARKETS
Read full article →
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
AACHEN, Germany, Jan. 9, 2025, 05:35 GMT-05
Grünenthal-appoints
Read full article →
Implantica announces new exceptional published data from the largest real-world study from Germany
VADUZ, Liechtenstein, Jan. 9, 2025, 02:56 GMT-05
IMPLANTICA-Clinical
Read full article →
Holistic care for senior citizen parents of NRIs: Policybazaar and insurer partners join hands for elderly support services
GURUGRAM, India, Jan. 9, 2025, 00:00 GMT-05
POLICYBAZAAR-New-Pdt
Read full article →
Holistic care for senior citizen parents of NRIs: Policybazaar and insurer partners join hands for elderly support services
GURUGRAM, India, Jan. 9, 2025, 20:00 GMT-05
POLICYBAZAAR-New-Pdt
Read full article →